Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

ARCA biopharma, Inc. (ABIO)

1.60 Down 0.01(0.62%) Apr 17, 3:59PM EDT
Get the big picture on all your investments.
ProfileGet Profile for:
ARCA biopharma, Inc.
8001 Arista Place
Suite 430
Broomfield, CO 80021
United States - Map
Phone: 720-940-2200
Fax: 720-208-9261

Index Membership:N/A
Full Time Employees:14

Business Summary 

ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatment of atrial fibrillation in patients with heart failure and left ventricular dysfunction. ARCA biopharma, Inc. is headquartered in Broomfield, Colorado.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on ARCA biopharma, Inc.

Key Executives 
Dr. Michael R. Bristow M.D., Ph.D., 69
Co-Founder, Chief Exec. Officer, Pres and Director
Mr. Patrick M. Wheeler , 45
Chief Financial Officer and Principal Accounting Officer
Mr. Christopher D. Ozeroff , 55
Sr. VP, Gen. Counsel and Sec.
Mr. Thomas A. Keuer , 55
Exec. VP of Operations
Mr. Derek K. Cole ,
VP of Investor Relations and Corp. Communications
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders